findmyKOL
Clinical trialNCT07443059RecruitingPhase 1Interventional

A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants

SponsorBeijing QL Biopharmaceutical Co.,LtdEnrollment40Overweight , Obesity
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a single-dose, open-label, parallel design phase I clinical study to evaluate the PK characteristics and safety of single subcutaneous injection of ZT002 Injection in participants with different degrees of renal insufficiency and matched participants with normal renal function.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Wei Zhao, PhD

    The First Affiliated of Shandong First Medical University

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China

    Not, yet, recruiting
  • the First Affiliated Hospital of Shandong First Medical Unversity

    Jinan, Shandong, China

    Recruiting
  • Sichuan Provincial People'S Hospital

    Chengdu, Sichuan, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Zovaglutide
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Apr 2026
Primary completion
3 Dec 2026
Completion
19 Mar 2027
Last update posted
20 Apr 2026
Registered enrollment
40
Registry id
NCT07443059
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.